Investigators showed that inhibition of the hyperactive mevalonate (MVA) metabolic pathway in tumor cells elicited type 1 classical dendritic cells-mediated tumor recognition and antigen cross-presentation for antitumor immunity.
[Cancer Research]
6445212 5QP3J8AI items 1 apa 0 default asc 1 164676 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-9e84593e590ac68c11283c8d0aac33d7%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225QP3J8AI%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xu%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EXu%2C%20F.%2C%20Wang%2C%20Z.%2C%20Zhang%2C%20H.%2C%20Chen%2C%20J.%2C%20Wang%2C%20X.%2C%20Cui%2C%20L.%2C%20Xie%2C%20C.%2C%20Li%2C%20M.%2C%20Wang%2C%20F.%2C%20Zhou%2C%20P.%2C%20Liu%2C%20J.%2C%20Huang%2C%20P.%2C%20Xia%2C%20X.%2C%20%26amp%3B%20Xia%2C%20X.%20%282021%29.%20Mevalonate%20blockade%20in%20cancer%20cells%20triggers%20CLEC9A%2B%20dendritic%20cell-mediated%20antitumor%20immunity.%20%3Ci%3ECancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-20-3977%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F0008-5472.CAN-20-3977%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D5QP3J8AI%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mevalonate%20blockade%20in%20cancer%20cells%20triggers%20CLEC9A%2B%20dendritic%20cell-mediated%20antitumor%20immunity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feifei%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zining%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongxia%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiemin%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaojuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lei%22%2C%22lastName%22%3A%22Cui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chunyuan%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mengyun%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Penghui%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinyun%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaodong%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaojun%22%2C%22lastName%22%3A%22Xia%22%7D%5D%2C%22abstractNote%22%3A%22Hyperactive%20mevalonate%20%28MVA%29%20metabolic%20activity%20is%20often%20observed%20in%20cancer%20cells%2C%20and%20blockade%20of%20this%20pathway%20inhibits%20tumor%20cell%20lipid%20synthesis%20and%20cell%20growth%20and%20enhances%20tumor%20immunogenicity.%20How%20tumor%20cell%20MVA%20metabolic%20blockade%20promotes%20antitumor%20immune%20responses%2C%20however%2C%20remains%20unclear.%20Here%20we%20show%20that%20inhibition%20of%20the%20MVA%20metabolic%20pathway%20in%20tumor%20cells%20elicits%20type%201%20classical%20dendritic%20cells%20%28cDC1%29-mediated%20tumor%20recognition%20and%20antigen%20cross-presentation%20for%20antitumor%20immunity.%20Mechanistically%2C%20MVA%20blockade%20disrupted%20prenylation%20of%20the%20small%20GTPase%20Rac1%20and%20induced%20cancer%20cell%20actin%20filament%20exposure%2C%20which%20was%20recognized%20by%20CLEC9A%2C%20a%20C-lectin%20receptor%20specifically%20expressed%20on%20cDC1s%2C%20in%20turn%20activating%20antitumor%20T%20cells.%20MVA%20pathway%20blockade%20or%20Rac1%20knockdown%20in%20tumor%20cells%20induced%20CD8%2B%20T%20cell-mediated%20antitumor%20immunity%20in%20immunocompetent%20mice%20but%20not%20in%20Batf3-%5C%2F-%20mice%20lacking%20CLEC9A%2B%20dendritic%20cells.%20These%20findings%20demonstrate%20tumor%20MVA%20metabolic%20blockade%20stimulates%20a%20cDC1%20response%20through%20CLEC9A-mediated%20immune%20recognition%20of%20tumor%20cell%20cytoskeleton%2C%20illustrating%20a%20new%20immune%20surveillance%20mechanism%20by%20which%20dendritic%20cells%20monitor%20tumor%20metabolic%20dysregulation%20and%20providing%20insight%20into%20how%20MVA%20pathway%20inhibition%20may%20potentiate%20anticancer%20immunity.%22%2C%22date%22%3A%222021%5C%2F01%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F0008-5472.CAN-20-3977%22%2C%22ISSN%22%3A%220008-5472%2C%201538-7445%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fcancerres.aacrjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2021%5C%2F07%5C%2F15%5C%2F0008-5472.CAN-20-3977%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-16T16%3A28%3A10Z%22%7D%7D%5D%7D
Xu, F., Wang, Z., Zhang, H., Chen, J., Wang, X., Cui, L., Xie, C., Li, M., Wang, F., Zhou, P., Liu, J., Huang, P., Xia, X., & Xia, X. (2021). Mevalonate blockade in cancer cells triggers CLEC9A+ dendritic cell-mediated antitumor immunity. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-20-3977 Cite